The Daily Papule

Monday 12 October

EJDMeta-analysisSystematic review
Biologic treatments for palmoplantar psoriasis and palmoplantar pustulosis
a systematic review and network meta-analysis.
Ayén-Rodríguez A, Ruiz-Villaverde R, Husein-Elahmed HEuropean Journal of Dermatology
Read at publisher(opens in a new tab)
J Cosmet Derm
OX40–OX40L Structural Insights Applied to Rocatinlimab in Atopic Dermatitis With Alopecia Areata Overlap
Mechanistic Hypotheses and Hair Regrowth
Khan WI, Malik ZZ, … senior author Yousafzai KAJournal of Cosmetic Dermatology
No abstractRead at publisher(opens in a new tab)
EJD
Improvement of disseminated superficial porokeratosis during tildrakizumab treatment for psoriasis vulgaris.
Zhang J, Kawakami Y, … senior author Morizane SEuropean Journal of Dermatology
No abstractRead at publisher(opens in a new tab)
EJDObservational study
Comparative drug survival of biologic classes in psoriasis
a Japanese single-centre cohort study.
Watabe D, Tsunoda K, … senior author Amano HEuropean Journal of Dermatology
Read at publisher(opens in a new tab)
JEADVObservational studyLetter
Role of disease duration, bio-naivety, MoA and BMI in predicting PASI 100 under biologic therapy.
Looser R, Steybe TM, … senior author Navarini AAJournal of the European Academy of Dermatology and Venereology
No abstractRead at publisher(opens in a new tab)
JDDGObservational study
Impact of IL-17A and IL-23p19 Inhibitors on Psychiatric Outcomes and Inflammation in Psoriasis.
Altunay IK, Demir A, … senior author Kul AJournal der Deutschen Dermatologischen Gesellschaft
Read at publisher(opens in a new tab)

Saturday 10 October

Derm Pract ConceptClinical trial
Less Is More
Cost-Effective Psoriasis Management via Disease-Driven Dosing of IL-17/IL-23 Inhibitors.
Cammarata E, Airoldi C, … senior author Savoia PDermatology Practical & Conceptual
Read at publisher(opens in a new tab)
DermatologySystematic review
Adalimumab in Generalized Granuloma Annulare: A Systematic Review.
Esteve-Boncompte G, Lulu A, … senior author Pietkiewicz PDermatology
Read at publisher(opens in a new tab)
Dermatology
One-Year Real-Life Data from Thai Patients with Moderate to Severe Plaque Psoriasis Treated with Secukinumab - Outcomes from the PROMPT Study.
Asawanonda P, Chularojanamontri L, … senior author Rattanakaemakorn PDermatology
Read at publisher(opens in a new tab)
JID Innov
Temporal outcomes and biomarkers of rituximab treatment response in pemphigus
Validation of a historical control dataset.
Rujitharanawong C, Tongsai S, Payne ASJID Innovations
Read at publisher(opens in a new tab)
Derm Pract ConceptLetter
Demodex Folliculitis Following Anifrolumab Infusion.
Bulosan H, Maier L, Kalus ADermatology Practical & Conceptual
No abstractRead at publisher(opens in a new tab)
Derm Pract ConceptReviewObservational study
Cutaneous Adverse Reactions to IL-17 and IL-23 Inhibitors
A Clinical Review of Reaction Patterns.
Park I, Bayrouti A, … senior author Nguyen KBDermatology Practical & Conceptual
Read at publisher(opens in a new tab)
JID InnovObservational study
Complete remission after rituximab therapy of pemphigus
Real-world evidence on dosing regimens and retreatment strategies.
Rujitharanawong C, Tongsai S, Payne ASJID Innovations
Read at publisher(opens in a new tab)
Derm Pract ConceptLetter
Palmoplantar Pustulosis Induced by Intravenous Anifrolumab
An Emerging Dermatologic Adverse Event?
Zanghì S, Bighetti S, … senior author Maione VDermatology Practical & Conceptual
No abstractRead at publisher(opens in a new tab)
Derm Pract ConceptObservational study
Interplay of Biological Treatment and Psychological Features in Patients with Psoriasis
A Real-Life Prospective Study.
Moretta G, Samela T, … senior author Abeni DDermatology Practical & Conceptual
Read at publisher(opens in a new tab)
Derm Pract ConceptLetter
Dupilumab in Epidermolysis Bullosa Pruriginosa
"All That Glisters Is Not Gold for Every Age".
Magnano M, Balestri R, … senior author Mazzatenta CDermatology Practical & Conceptual
No abstractRead at publisher(opens in a new tab)
JAADLetter
When siblings become caregivers
Balancing participation and protection in dermatology.
Islam RK, Wu JJJournal of the American Academy of Dermatology
No abstractRead at publisher(opens in a new tab)

Friday 9 October

BJD
Towards Personalised Therapeutics for Epidermal Differentiation Disorders
Integrating Host Genetics, Immuno-Endotypes and the Skin Microbiome.
Sharkey T, Eisner M, … senior author Rajan NBritish Journal of Dermatology
Read at publisher(opens in a new tab)

Thursday 8 October

Pediatr DermCase report
Pediatric Lichen Planus Pemphigoides in a Child With Sickle Cell Disease
Cyclosporine Induction and Dupilumab Maintenance.
Engelking YT, Ferrer LC, … senior author Berrebi KGPediatric Dermatology
Read at publisher(opens in a new tab)
Pediatr DermObservational study
Impact of Biologic Therapy on Emergency Department Utilization in Pediatric Hidradenitis Suppurativa Patients.
Kherallah K, Chung CS, … senior author Lee KHPediatric Dermatology
Read at publisher(opens in a new tab)

Journals and topics

Biologics

Monday 12 October

Biologic treatments for palmoplantar psoriasis and palmoplantar pustulosis

OX40–OX40L Structural Insights Applied to Rocatinlimab in Atopic Dermatitis With Alopecia Areata Overlap

Improvement of disseminated superficial porokeratosis during tildrakizumab treatment for psoriasis vulgaris.

Comparative drug survival of biologic classes in psoriasis

Role of disease duration, bio-naivety, MoA and BMI in predicting PASI 100 under biologic therapy.

Impact of IL-17A and IL-23p19 Inhibitors on Psychiatric Outcomes and Inflammation in Psoriasis.

Saturday 10 October

Less Is More

Adalimumab in Generalized Granuloma Annulare: A Systematic Review.

One-Year Real-Life Data from Thai Patients with Moderate to Severe Plaque Psoriasis Treated with Secukinumab - Outcomes from the PROMPT Study.

Temporal outcomes and biomarkers of rituximab treatment response in pemphigus

Demodex Folliculitis Following Anifrolumab Infusion.

Cutaneous Adverse Reactions to IL-17 and IL-23 Inhibitors

Complete remission after rituximab therapy of pemphigus

Palmoplantar Pustulosis Induced by Intravenous Anifrolumab

Interplay of Biological Treatment and Psychological Features in Patients with Psoriasis

Dupilumab in Epidermolysis Bullosa Pruriginosa

When siblings become caregivers

Friday 9 October

Towards Personalised Therapeutics for Epidermal Differentiation Disorders

Thursday 8 October

Pediatric Lichen Planus Pemphigoides in a Child With Sickle Cell Disease

Impact of Biologic Therapy on Emergency Department Utilization in Pediatric Hidradenitis Suppurativa Patients.